Mar 20, 2019
Medtronic has reported results from the WRAP-IT trial of its TYRX envelope in patients with cardiac implantable electronic devices (CIEDs).
TYRX is a mesh envelope designed to hold an implantable cardiac device or implantable neurostimulator. It stabilises the device after implantation, as well as releases antimicrobial agents, minocycline and rifampin over a minimum of seven days. The envelope is fully absorbed around nine weeks after implantation.